China’s MOH Issues Notice On Strengthening Drug Use Surveillance
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Health recently circulated a working draft on strengthening rational drug use surveillance nationwide. The scheme is jointly formulated by MOH, State Administration of Traditional Chinese Medicine and the health bureau under the General Logistics Department of the People's Liberation Army. MOH demands that all provincial-level health authorities instruct monitoring site hospitals in each council area to implement relevant work; these hospitals should ensure smooth progress in their surveillance. MOH will mainly be responsible for the surveillance work in grade three hospitals, while provincial health authorities will be in charge of rational drug use monitoring in grade two hospitals and basic-level health care institutions. (Click here for more - Chinese Language)